Cefaclor description: Difference between revisions
No edit summary |
|||
| Line 15: | Line 15: | ||
Each 250-mg capsule contains cefaclor monohydrate equivalent to 250 mg (0.68 mmol) of anhydrous cefaclor and inactive ingredients: magnesium stearate,sodium starch glycolate, lactose monohydrate, talc. The 250 mg capsule shell contains gelatin, titanium dioxide, and imprinting ink components: shellac, strong ammonia solution, potassium hydroxide, black iron oxide, dehydrated alcohol, isopropyl alcohol, butyl alcohol and propylene glycol. | Each 250-mg capsule contains cefaclor monohydrate equivalent to 250 mg (0.68 mmol) of anhydrous cefaclor and inactive ingredients: magnesium stearate,sodium starch glycolate, lactose monohydrate, talc. The 250 mg capsule shell contains gelatin, titanium dioxide, and imprinting ink components: shellac, strong ammonia solution, potassium hydroxide, black iron oxide, dehydrated alcohol, isopropyl alcohol, butyl alcohol and propylene glycol. | ||
Each 500-mg capsule contains cefaclor monohydrate equivalent to 500 mg (1.36 mmol) of anhydrous cefaclor and inactive ingredients: magnesium stearate,sodium starch glycolate, lactose monohydrate, talc. The 500 mg capsule shell contains gelatin, titanium dioxide, and imprinting ink components: shellac, strong ammonia solution, titanium dioxide, aluminum lake, dehydrated alcohol, isopropyl alcohol, butyl alcohol and propylene glycol. | Each 500-mg capsule contains cefaclor monohydrate equivalent to 500 mg (1.36 mmol) of anhydrous cefaclor and inactive ingredients: magnesium stearate,sodium starch glycolate, lactose monohydrate, talc. The 500 mg capsule shell contains gelatin, titanium dioxide, and imprinting ink components: shellac, strong ammonia solution, titanium dioxide, aluminum lake, dehydrated alcohol, isopropyl alcohol, butyl alcohol and propylene glycol.<ref>{{Cite web | last = |first = |title = http://www.accessdata.fda.gov/drugsatfda_docs/nda/98/64081_Cefaclor_Approv.pdf |url =http://www.accessdata.fda.gov/drugsatfda_docs/nda/98/64081_Cefaclor_Approv.pdf publisher = |date = | accessdate = }}</ref> | ||
==References== | ==References== | ||
{{Reflist}} | {{Reflist}} | ||
Revision as of 15:26, 24 December 2013
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Description
Cefaclor, USP is a semisynthetic cephalosporin antibiotic for oral administration. It is chemically designated as 3-chloro-7-D-(2-phenylglycinamido) -3-cephem-4-carboxylic acid monohydrate. The chemical formula for cefaclor is C15H14ClN3O4S·H2O and the molecular weight is 385.82.
 |
Each 250-mg capsule contains cefaclor monohydrate equivalent to 250 mg (0.68 mmol) of anhydrous cefaclor and inactive ingredients: magnesium stearate,sodium starch glycolate, lactose monohydrate, talc. The 250 mg capsule shell contains gelatin, titanium dioxide, and imprinting ink components: shellac, strong ammonia solution, potassium hydroxide, black iron oxide, dehydrated alcohol, isopropyl alcohol, butyl alcohol and propylene glycol.
Each 500-mg capsule contains cefaclor monohydrate equivalent to 500 mg (1.36 mmol) of anhydrous cefaclor and inactive ingredients: magnesium stearate,sodium starch glycolate, lactose monohydrate, talc. The 500 mg capsule shell contains gelatin, titanium dioxide, and imprinting ink components: shellac, strong ammonia solution, titanium dioxide, aluminum lake, dehydrated alcohol, isopropyl alcohol, butyl alcohol and propylene glycol.[1]
References
- ↑ publisher = "http://www.accessdata.fda.gov/drugsatfda_docs/nda/98/64081_Cefaclor_Approv.pdf" Check
|url=value (help). External link in|title=(help)
Adapted from the FDA Package Insert.
References
Adapted from the FDA Package Insert.